- Code
- J0791
- Description
- Injection, crizanlizumab-tmca, 5 mg
NDC crosswalk
- 00078-0883-61 Adakveo, Novartis Pharmaceuticals Corporation. Billable units per 11-digit NDC: 20.
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.